 |
Cover
Story:
What’s Next for Biotech?
By Frank Ferrara
The biotech industry has been through a remarkably volatile period over the last 10 years, from the heady days of the late-‘90s IPO gold rush and the promise held out by the completion of the Human Genome Project, to the challenges presented by today’s tighter venture capital markets and changing regulatory climate. Is biotech, once touted as the future of healthcare, still poised for big things, and what will this mean for the physicians and patients who depend on the innovations created by this industry?
|
| |
PDA Resources:
We offer a collection of programs, downloads, and extras designed to help you get the most out of your handheld computing.
Newswatch:
Our regular roundup of recent, significant legislative and regulatory developments, and important bulletins from medical societies and organizations, patient advocacy groups, and official government agencies just got better. All content is now provided by MedPage Today. |
